Kondreddy Naveen at 18:02, 8 March 2024

2024-03-08T18:02:41Z

New page

== '''What is Enobosarm?''' ==

* Enobosarm, also known by its developmental code name GTx-024 and trade name '''Ostarine''', is '''a selective androgen receptor modulator''' (SARM) that has gained attention for its potential therapeutic applications in [[muscle wasting]] conditions, [[osteoporosis]], and other disorders.

[[File:Ostarine.svg|thumb|Ostarine]]

<youtube>
title='''{{PAGENAME}}'''
movie_url=http://www.youtube.com/v/v=d3s1dSNP8Ns
embed_source_url=http://www.youtube.com/v/v=d3s1dSNP8Ns
&rel=1
wrap = yes
width=750
height=600
</youtube>

== '''Mechanism of Action''' ==

* Enobosarm functions by '''selectively binding to androgen receptors in tissues such as muscles and bones'''.
* Unlike traditional [[anabolic steroids]], which can have a broad impact on various tissues including the prostate and liver, enobosarm's selective nature means it '''primarily targets androgen receptors in specific areas'''.
* Upon binding to these receptors, '''enobosarm modulates gene expression, promoting [[anabolic]] effects in muscle tissue and bone'''.
* This makes it a potential therapeutic agent for conditions involving muscle wasting, bone density loss, and frailty.

[[File:Ostarine.png|thumb|Ostarine]]

== '''Medical Uses''' ==

* Enobosarm has been investigated for several potential medical uses:

[[File:2010-04-23 Ostarine vs Andarine.TIF|thumb|2010-04-23 Ostarine vs Andarine]]

=== 1. Muscle Wasting ===
* Enobosarm has shown promise in preventing and treating [[muscle wasting]] conditions, including those related to cancer, [[chronic obstructive pulmonary disease]] (COPD), and other chronic illnesses.
* By promoting muscle growth and preventing muscle loss, it may improve patients' quality of life and overall physical function.

=== 2. Osteoporosis ===
* Research suggests that enobosarm may have a positive impact on bone health by increasing [[bone mineral density]] and reducing the risk of fractures.
* This potential makes it an intriguing option for [[osteoporosis]] treatment and prevention.

=== 3. Hormone Replacement Therapy ===
* Enobosarm's selective androgen receptor modulation could potentially provide an alternative to traditional hormone replacement therapies for individuals with androgen deficiencies.

== '''Clinical Trials''' ==

* Enobosarm has been studied extensively in clinical trials to assess its safety, efficacy, and potential benefits.
* Research has focused on various patient populations, including those with muscle wasting disorders and [[osteoporosis]].
* Many trials have reported positive outcomes related to muscle mass, physical function, and bone health.
* However, it's important to note that enobosarm is still being researched, and further studies are needed to fully establish its safety profile and long-term effects.

== '''Side Effects''' ==

* Enobosarm has generally shown a favorable safety profile in clinical trials.
* Reported side effects have been mild and include headache, back pain, and [[nausea]].
* Additionally, because enobosarm is a SARM and not a traditional [[anabolic steroid]], it may have a reduced risk of causing [[Hormonal imbalance|hormonal imbalances]] and related side effects.

== '''Regulatory Status''' ==

* Enobosarm has not received full regulatory approval in many countries as of the current date.
* It is important to recognize that its development and regulatory status may vary by region.
* Some countries may permit its use in clinical trials, while others may not have approved it for any use.

== '''Conclusion''' ==

* Enobosarm, as '''a selective androgen receptor modulator''', holds promise for addressing [[muscle wasting]], [[osteoporosis]], and potentially other conditions.
* Its selective binding to [[androgen receptors]] offers the potential for therapeutic benefits with fewer side effects compared to traditional anabolic steroids.
* While research is ongoing and regulatory approvals are pending in some regions, enobosarm's potential applications in improving muscle health and [[bone density]] are of significant interest to the medical community.
* Continued research will provide a clearer understanding of its benefits and safety profile.

== '''References''' ==

* Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):153-61. doi: 10.1007/s13539-011-0034-6. PMID: 22031847; PMCID: PMC3177038.
* Cilotti A, Falchetti A, Banti C, et al. Ostarine (GTx-024, MK-2866): a Selective Androgen Receptor Modulator (SARM) for treatment of muscle-wasting related to cancer, osteoporosis and aging. Report on the consensus meeting. Rome, 8-9 October 2015. J Endocrinol Invest. 2016 Feb;39(2):117-22. doi: 10.1007/s40618-015-0352-y. Epub 2016 Jan 8. PMID: 26738792.

{{coststubd}}
{{Androgen receptor modulators}}

[[Category:Acetanilides]]
[[Category:Tertiary alcohols]]
[[Category:Nitriles]]
[[Category:Phenol ethers]]
[[Category:Selective androgen receptor modulators]]
[[Category:Trifluoromethyl compounds]]

Enobosarm - Revision history

Kondreddy Naveen at 18:02, 8 March 2024